ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Immunoglobulin (IVIg) Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-26Q396
Home | Market Reports
Global Intravenous Immunoglobulin IVIg Market Insights and Forecast to 2028
BUY CHAPTERS

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2026

Code: QYRE-Auto-26Q396
Report
2026-01-21
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Grifols S A
CSL Limited
Octapharma AG
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg) Market Size

The global Intravenous Immunoglobulin (IVIg) market was valued at US$ 12170 million in 2025 and is anticipated to reach US$ 18070 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Intravenous Immunoglobulin (IVIg) Market

Intravenous Immunoglobulin (IVIg) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Intravenous Immunoglobulin (IVIg) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
This report delivers a comprehensive overview of the global Intravenous Immunoglobulin (IVIg) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg). The Intravenous Immunoglobulin (IVIg) market size, estimates, and forecasts are provided in terms of sales volume (K Bottle) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Intravenous Immunoglobulin (IVIg) Market Report

Report Metric Details
Report Name Intravenous Immunoglobulin (IVIg) Market
Accounted market size in 2025 US$ 12170 million
Forecasted market size in 2032 US$ 18070 million
CAGR 5.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • IVIg Liquid
  • IVIg Powder
by Application
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Intravenous Immunoglobulin (IVIg) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Intravenous Immunoglobulin (IVIg) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Intravenous Immunoglobulin (IVIg) Market growing?

Ans: The Intravenous Immunoglobulin (IVIg) Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Intravenous Immunoglobulin (IVIg) Market size in 2032?

Ans: The Intravenous Immunoglobulin (IVIg) Market size in 2032 will be US$ 18070 million.

What is the market share of major companies in Intravenous Immunoglobulin (IVIg) Market?

Ans: Global top four manufacturers hold a share above 65%.

What is the Intravenous Immunoglobulin (IVIg) Market share by region?

Ans: North America is the largest market, with a share about 45%.

Who are the main players in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The main players in the Intravenous Immunoglobulin (IVIg) Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Applications covered in the Intravenous Immunoglobulin (IVIg) Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Intravenous Immunoglobulin (IVIg) Market report?

Ans: The Types covered in the Intravenous Immunoglobulin (IVIg) Market report are IVIg Liquid, IVIg Powder

1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Definition
1.2 Intravenous Immunoglobulin (IVIg) by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Value by Type: 2025 vs 2032
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Value by Application: 2025 vs 2032
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2021–2032
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2021–2032
1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Types and Applications
2.7 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Entry into the Industry
2.8 Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.8.1 Global Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.8.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Immunoglobulin (IVIg) Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021–2032
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2021–2026
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2027–2032
3.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2021–2032
3.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2021–2026
3.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2027–2032
3.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2021–2032)
3.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2021–2032)
3.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2021–2032)
3.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2021–2032)
3.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021–2032)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2021–2026)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2027–2032)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021–2032)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021–2032)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2021–2026)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2027–2032)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021–2032)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021–2032)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2021–2026)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2027–2032)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021–2032)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021–2032)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2021–2026)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2027–2032)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021–2032)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
7.2 Intravenous Immunoglobulin (IVIg) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process Analysis
7.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
7.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
7.4.2 Intravenous Immunoglobulin (IVIg) Distributors
7.5 Intravenous Immunoglobulin (IVIg) Customer Analysis
8 Intravenous Immunoglobulin (IVIg) Market Dynamics
8.1 Intravenous Immunoglobulin (IVIg) Industry Trends
8.2 Intravenous Immunoglobulin (IVIg) Market Drivers
8.3 Intravenous Immunoglobulin (IVIg) Market Challenges
8.4 Intravenous Immunoglobulin (IVIg) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter
Grifols S A
CSL Limited
Octapharma AG
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
List of Tables
 Table 1. Global Intravenous Immunoglobulin (IVIg) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Manufacturers (2021–2026)
 Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Types and Applications
 Table 12. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Immunoglobulin (IVIg) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Intravenous Immunoglobulin (IVIg) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Intravenous Immunoglobulin (IVIg) Sales by Region (K Bottle), 2021–2026
 Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021–2026)
 Table 19. Global Intravenous Immunoglobulin (IVIg) Sales by Region (K Bottle), 2027–2032
 Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2027–2032)
 Table 21. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021–2026)
 Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2027–2032)
 Table 25. North America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2021–2026
 Table 27. North America Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2027–2032
 Table 28. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2021–2026
 Table 32. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2027–2032
 Table 33. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (K Bottle), 2021–2026
 Table 37. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (K Bottle), 2027–2032
 Table 38. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2021–2026
 Table 42. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2027–2032
 Table 43. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2021–2026
 Table 47. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (K Bottle), 2027–2032
 Table 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2021–2026)
 Table 51. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2027–2032)
 Table 52. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2021–2026)
 Table 53. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2027–2032)
 Table 54. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2021–2026)
 Table 57. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2027–2032)
 Table 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2021–2026)
 Table 59. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2027–2032)
 Table 60. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2021–2026)
 Table 61. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2027–2032)
 Table 62. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2021–2026)
 Table 63. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2027–2032)
 Table 64. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2021–2026)
 Table 67. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2027–2032)
 Table 68. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2021–2026)
 Table 69. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2027–2032)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 73. Baxter Intravenous Immunoglobulin (IVIg) Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 78. Grifols Intravenous Immunoglobulin (IVIg) Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 83. CSL Intravenous Immunoglobulin (IVIg) Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Biotest Company Information
 Table 91. Biotest Description and Business Overview
 Table 92. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 93. Biotest Intravenous Immunoglobulin (IVIg) Product
 Table 94. Biotest Recent Developments/Updates
 Table 95. Kedrion Company Information
 Table 96. Kedrion Description and Business Overview
 Table 97. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 98. Kedrion Intravenous Immunoglobulin (IVIg) Product
 Table 99. Kedrion Recent Developments/Updates
 Table 100. Hualan Bio Company Information
 Table 101. Hualan Bio Description and Business Overview
 Table 102. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 103. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
 Table 104. Hualan Bio Recent Developments/Updates
 Table 105. CNBG Company Information
 Table 106. CNBG Description and Business Overview
 Table 107. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 108. CNBG Intravenous Immunoglobulin (IVIg) Product
 Table 109. CNBG Recent Developments/Updates
 Table 110. Shanghai RAAS Company Information
 Table 111. Shanghai RAAS Description and Business Overview
 Table 112. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 113. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
 Table 114. Shanghai RAAS Recent Developments/Updates
 Table 115. CBPO Company Information
 Table 116. CBPO Description and Business Overview
 Table 117. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 118. CBPO Intravenous Immunoglobulin (IVIg) Product
 Table 119. CBPO Recent Developments/Updates
 Table 120. LFB Group Company Information
 Table 121. LFB Group Description and Business Overview
 Table 122. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 123. LFB Group Intravenous Immunoglobulin (IVIg) Product
 Table 124. LFB Group Recent Developments/Updates
 Table 125. BPL Company Information
 Table 126. BPL Description and Business Overview
 Table 127. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 128. BPL Intravenous Immunoglobulin (IVIg) Product
 Table 129. BPL Recent Developments/Updates
 Table 130. Sichuan Yuanda Shuyang Company Information
 Table 131. Sichuan Yuanda Shuyang Description and Business Overview
 Table 132. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle), and Gross Margin (2021–2026)
 Table 133. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
 Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Intravenous Immunoglobulin (IVIg) Distributors List
 Table 138. Intravenous Immunoglobulin (IVIg) Customers List
 Table 139. Intravenous Immunoglobulin (IVIg) Market Trends
 Table 140. Intravenous Immunoglobulin (IVIg) Market Drivers
 Table 141. Intravenous Immunoglobulin (IVIg) Market Challenges
 Table 142. Intravenous Immunoglobulin (IVIg) Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
 Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Share by Type: 2025 & 2032
 Figure 4. IVIg Liquid Product Picture
 Figure 5. IVIg Powder Product Picture
 Figure 6. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Intravenous Immunoglobulin (IVIg) Market Share by Application: 2025 & 2032
 Figure 8. Immunodeficiency
 Figure 9. Autoimmune Disease
 Figure 10. Acute Infection
 Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size (US$ Million), 2021–2032
 Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle), 2021–2032
 Figure 14. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle), 2021–2032
 Figure 15. Intravenous Immunoglobulin (IVIg) Report Years Considered
 Figure 16. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2025
 Figure 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Intravenous Immunoglobulin (IVIg) Players: Market Share by Revenue in Intravenous Immunoglobulin (IVIg) in 2025
 Figure 19. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021–2032)
 Figure 22. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021–2032)
 Figure 26. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2021–2032)
 Figure 34. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type (2021–2032)
 Figure 55. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Application (2021–2032)
 Figure 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2021–2032)
 Figure 59. Intravenous Immunoglobulin (IVIg) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Injection Immunoglobulin Market Research Report 2024
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulin Product Market Research Report 2024
Global Human Hyperimmune Globulins Market Research Report 2024
Global Hyperimmune Globulin Injection Market Research Report 2024
Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immune Globulin Therapies Market Research Report 2024
Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulins Market Research Report 2025
Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immunoglobulin IVIg Therapy Market Research Report 2025
Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024
Human Normal Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions